Integrated genetic and clinical prognostic factors for aggressive adult T-cell leukemia/lymphoma.

Haematologica(2023)

引用 0|浏览22
暂无评分
摘要
The prognosis of aggressive adult T-cell leukemia/lymphoma (ATL) is poor, and allogeneic hematopoietic stem-cell transplantation (allo-HSCT) is a curative treatment. To identify favorable prognostic patients after intensive chemotherapy, and who therefore might not require upfront allo-HSCT, we aimed to improve risk stratification of aggressive ATL patients aged.
更多
查看译文
关键词
clinical prognostic factors,t-cell
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要